Nuvalent, Inc. · 8 hours ago
Director, Scientific Communications
United States
Full-time
Remote
Director/Executive
$220K/yr - $250K/yr
8+ years expNuvalent is an exciting early-stage company focused on creating selective medicines for cancer patients. The Director of Scientific Communications will lead the publication and data dissemination strategy, collaborating with various teams to ensure effective communication and publication planning.
BiotechnologyLife ScienceTherapeutics
Responsibilities
Lead asset publication and communications strategy, planning, and execution
Collaborate cross-functionally on publication planning and execution
Partner with Clinical Development, Medical Affairs, Evidence Generation, and Brand teams to identify and prioritize data gaps and publication concepts
Co-lead Publication Planning Committee, including driving agendas, documenting meeting minutes, and managing action items
Manage approval of publication strategy and plans by the Publication Planning Committee and endorsement by PDT and LT
Oversee all aspects of publication development for abstracts, congress presentations, manuscripts, reviews, publication extenders, etc
Critically review drafts and adjudicate comments
Drive development and updates of the asset scientific platform and lexicon in collaboration with cross-functional teams; ensure utilization to drive consistency across all related medical materials and channels
Support portfolio-wide publications as needed
Publication management platform oversight (eg, Datavision or similar platform)
Support data dissemination strategy and plans across various Medical Affairs initiatives, including content development, congress activities, and medical education initiatives
Subject matter expert on disease state, competitive landscape, and publication benchmarks
Manage vendors, ensuring adherence to timelines, process, and publication best practices
Qualification
Required
Advanced degree (PhD, PharmD, MD/DO, NP, PA-C or equivalent) in a relevant scientific discipline
8+ years of experience in the pharmaceutical biotech or other relevant industries
4 years of experience in publications
Demonstrated experience developing and executing publication strategy and plans
Oncology experience required; lung cancer experience strongly preferred
Experience managing medical communications vendors
In-depth knowledge of GPP and ICMJE criteria
Strong project management skills, with high attention to detail and ability to prioritize and deliver multiple projects simultaneously
Effective oral, written, and interpersonal skills required
Preferred
Oncology experience strongly preferred
Benefits
Medical, dental, and vision insurance
401(k) retirement savings plan
Generous paid time off (including a summer and winter company shutdown)
Company
Nuvalent, Inc.
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.82BKey Investors
Bain Capital Life SciencesDeerfield
2025-11-18Post Ipo Secondary· $500M
2024-09-16Post Ipo Equity· $575M
2023-10-16Post Ipo Equity· $300M
Leadership Team
James Porter
CEO
Alexandra Balcom
Chief Financial Officer
Recent News
MarketScreener
2025-12-16
Company data provided by crunchbase